http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3833666-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9a36328274867f46f8fc1fb9c868703
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-06
filingDate 2019-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8baa2a5415cf42075d3d6d61aff2f41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c9e67dada10a2d4416905b78581d6f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_229a7a490e3653b28bc633cafbe0f70d
publicationDate 2021-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3833666-A1
titleOfInvention Process and intermediates for the preparation of boc-linagliptin
abstract This invention relates to novel processes for the synthesis of Linagliptin, the pharmaceutically active ingredient, and the key intermediate thereof, BOC-Linagliptin. (I) The processes are performed via new intermediate compounds of Formula (5) and Formula (3).
priorityDate 2018-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226441952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226441953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10096344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226987224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146346632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146346613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226936885
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID405788381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20502412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146346615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3704368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID405788409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226987225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228304246
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21972794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID405788361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146346631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146346659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID405788363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226523537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID405788373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226648455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID272730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID405788380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146346625

Total number of triples: 48.